Mechanisms Underlying the Cardiovascular Effects of COX-Inhibition: Benefits and Risks

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|22|2215-2227

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.22, 2007-08, pp. : 2215-2227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Beyond Cox-Inhibition: ‘Side-Effects’ of Ibuprofen on Neoplastic Development and Progression

By  

Current Pharmaceutical Design, Vol. 21, Iss. 21, 2015-06 ,pp. : 2978-2982

Bentham Science Publishers

Access to resources Recommend Favorite

Cardiovascular and Renovascular Implications of COX-2 Inhibition

By  

Current Pharmaceutical Design, Vol. 10, Iss. 6, 2004-02 ,pp. : 603-611

Bentham Science Publishers

Access to resources Recommend Favorite

Low Dose Aspirin, COX-Inhibition and Chemoprevention of Colorectal Cancer

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 5, 2005-06 ,pp. : 493-503

Bentham Science Publishers

Access to resources Recommend Favorite

Prevention of Cancer in the Upper Gastrointestinal Tract with COX-Inhibition. Still an Option?

By  

Current Pharmaceutical Design, Vol. 13, Iss. 22, 2007-08 ,pp. : 2261-2273

Bentham Science Publishers

Access to resources Recommend Favorite

Mechanisms Underlying the Hepatotoxic Effects of Ecstasy

By  

Current Pharmaceutical Biotechnology, Vol. 11, Iss. 5, 2010-08 ,pp. : 476-495

Bentham Science Publishers

Access to resources Recommend Favorite